Primary Debulking Surgery Bests Neoadjuvant Chemo in High-Grade Serous Ovarian Cancer
Earlier detection of primary ovarian tumor could extend survival in some patients When complete...
Read MoreJun 16, 2021
Earlier detection of primary ovarian tumor could extend survival in some patients When complete...
Read MoreJun 8, 2021
Good anti-tumor activity and manageable safety profile seen When added to concurrent...
Read MoreJun 8, 2021
Confirmed response seen in patients who relapse after osimertinib Patients with non-small cell...
Read MoreJun 8, 2021
Objective response observed at 1.4 months Targeted therapies have greatly improved outcomes in...
Read MoreJun 7, 2021
Survival benefit seen in early-stage HER-2 negative breast cancer with BRCA1/2 mutations Adding 12...
Read MoreJun 5, 2021
Significant improvements in mortality among non-small cell lung cancer (NSCLC) cancer patients have been reported over the past 2 decades, according to Surveillance, Epidemiology, and End Results Program (SEER) data. The timing...
Read MoreJun 5, 2021
Liquid biopsies based on circulating tumor DNA (ctDNA) analysis are being investigated for detection of residual disease and recurrence in patients with early-stage non-small cell lung cancer (NSCLC). Due to low ctDNA levels in...
Read MoreJun 4, 2021
Herpes zoster (HZ) is prevalent in patients with Chronic Lymphocytic Leukemia (CLL) and affects younger patients who require chemotherapy. The risk of developing HZ increases in recipients of first and second line chemotherapy....
Read MoreJun 4, 2021
Survival is significantly improved by calendar period among patients diagnosed after 2004 and treated in the era of advanced therapies. Females and younger patients had a higher probability of long term survival. The survival of...
Read MoreJun 4, 2021
A 24-month phone and app/web-based diet and physical activity intervention that was successful for weight loss in the general population did not result in greater weight loss or improvement in cardiovascular (CV) risk factors...
Read MoreJun 4, 2021
This study demonstrated for the first time that human peripheral blood mononuclear cells (PBMCs) from chronic lymphocytic leukemia (CLL) patients can be converted into NK cells, CD8+ T cells, NKT cells, and TCRγδ T cells...
Read MoreJun 4, 2021
Palliative care and coping in patients with acute myeloid leukemia receiving intensive induction therapy: A mediation analysis of data from a randomized trial. Integrated palliative and oncology care (IPC) as part of...
Read MoreJun 4, 2021
Progression-free survival (PFS) and second PFS (PFS2) by disease stage in patients (pts) with homologous recombination deficiency (HRD)-positive newly diagnosed advanced ovarian cancer receiving bevacizumab (bev) with...
Read MoreJun 4, 2021
Evidence indicates that balancing treatment efficacy with complication risk is critically important for older adults with non-Hodgkin’s lymphoma (NHL); however, the survival outcomes, rates of toxicities, and healthcare...
Read MoreJun 4, 2021
Although previous studies suggest positive outcomes with novel salvage therapies for patients with relapsed/refractory classic Hodgkin’s lymphoma who are eligible for autologous stem cell transplant, the efficacies and outcomes...
Read MoreJun 4, 2021
Prior research indicates that survivors of non-Hodgkin’s lymphoma are at increased risk of secondary malignancies. However, data are lacking on long-term risk and whether such risk differs by treatment modality. Investigators...
Read MoreJun 4, 2021
To determine whether a correlation exists between baseline tumor burden and early tumor progression based on imaging in patients with diffuse large B-cell lymphoma (DLBCL) and Hodgkin’s lymphoma (HL), researchers analyzed...
Read MoreJun 4, 2021
With limited data on the real-world treatment of follicular lymphoma in a contemporary cohort of patients, researchers examined treatment patterns and outcomes among nearly 2,400 adult patients with an initial follicular...
Read MoreJun 4, 2021
Immunotherapy (IO) + chemotherapy ± anti-angiogenics comprise FDA-approved 1L regimens for metastatic non-small cell lung cancer (NSCLC), with IO-only therapy approved only for PD-L1+ NSCLC. Patients with PD-L1 scores from...
Read MoreJun 4, 2021
Survival outcomes for patients with adenosquamous carcinoma of the lung are not well understood by virtue of reduced prevalence. To address this, a recent study sought to compare the long-term survival among patients with...
Read More